IPO
In Conversation: Matthew McKnight, Chief Commercial Officer, Ginkgo Bioworks
Synthetic.com’s publisher and editor, Simons Chase, interviews Matthew McKnight. Matt is the Chief Commercial Officer of Ginkgo Bioworks where h...
DISCOVERIES
How Immune Macrophages Communicate
Students of synthetic biology soon discover that living things are more adaptive and creative than most people ever imagined. According to Perry Marsh...
STARTUPS
Strand Therapeutics Wins NIH CAR-T Cell Immunotherapy Contract
Strand Therapeutics, a privately held biotech company developing next-generation, programmable mRNA therapeutics beyond vaccines, announced last week ...
SCIENCE
Mayo Clinic Reports mRNA Progress In Cancer Treatment
Mayo Clinic research shows treatment improvement by adding messenger RNA, or mRNA therapy improves the response to cancer immunotherapy in patients wh...
